Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

Rservlogix large

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free

Reply New Message

Back To Forum List View

Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

4

Jun 12, 2023 07:23AM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

2

Nextblockbuster

Jun 12, 2023 06:15PM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

11

Jun 13, 2023 08:02AM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

9

Jun 13, 2023 08:21AM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

6

Jun 13, 2023 09:08AM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

3

Jun 13, 2023 11:58AM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

2

Jun 13, 2023 12:32PM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

3

Jun 13, 2023 12:33PM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

4

Jun 13, 2023 05:38PM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

7

Jun 13, 2023 07:24PM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

4

Jun 13, 2023 07:25PM

KOO-KOO2

Rank: Treasurer [?]

Points: 10734 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

in response to

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

by

posted on Jun 14, 2023 07:25AM

Log in to use the IP Check tool ^[?]

The attendees are having a difficult time sourcing green fuel for the Ferrari to get it back on the speedway .... assuming that is all it needs to get to the finish line, victoriously.

Koo

1 Recommendations

Loading...

Loading...

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

3

Jun 14, 2023 09:18AM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

Jun 14, 2023 03:46PM

Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

1

Jun 14, 2023 03:47PM

Reply New Message

Back To Forum List View

Share

Share

Share

Please to post a reply